GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acrobiosystems Co Ltd (SZSE:301080) » Definitions » Research & Development

Acrobiosystems Co (SZSE:301080) Research & Development : ¥133.0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Acrobiosystems Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Acrobiosystems Co's Research & Development for the three months ended in Mar. 2024 was ¥36.8 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was ¥133.0 Mil.

Acrobiosystems Co Research & Development Historical Data

The historical data trend for Acrobiosystems Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acrobiosystems Co Research & Development Chart

Acrobiosystems Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial 21.31 30.65 59.56 113.85 124.92

Acrobiosystems Co Quarterly Data
Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.79 31.82 33.43 30.88 36.84

Acrobiosystems Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥133.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acrobiosystems Co  (SZSE:301080) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Acrobiosystems Co Research & Development Related Terms

Thank you for viewing the detailed overview of Acrobiosystems Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Acrobiosystems Co (SZSE:301080) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acrobiosystems Co Ltd (SZSE:301080) » Definitions » Research & Development
Comparable Companies
SHSE:688319 SHSE:603439 SHSE:688658 SHSE:603718 SHSE:603896 SZSE:300181 SHSE:600200 SHSE:603566 SHSE:688046 SZSE:301333 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
No. 8, Hongda North Road, 4th Floor, Building 4, Beijing Economic and Technological Development Zon, Beijing, CHN, 100176
Website
https://www.acrobiosystems.cn
Acrobiosystems Co Ltd is a global brand focusing on protein technology, products and services in the development of biological drugs. It is committed to providing target antigens and other key reagents and related services required in the development of targeted therapeutic drugs.

Acrobiosystems Co (SZSE:301080) Headlines

No Headlines